Barclays’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.79M | Sell |
19,848
-10,001
| -34% | -$2.41M | ﹤0.01% | 1659 |
|
|
2025
Q1 | $7.27M | Sell |
29,849
-10,570
| -26% | -$2.57M | ﹤0.01% | 1197 |
|
|
2024
Q4 | $13.3M | Sell |
40,419
-1,557
| -4% | -$511K | ﹤0.01% | 953 |
|
|
2024
Q3 | $14M | Sell |
41,976
-5,406
| -11% | -$1.81M | ﹤0.01% | 869 |
|
|
2024
Q2 | $12.9M | Buy |
47,382
+7,528
| +19% | +$2.06M | ﹤0.01% | 820 |
|
|
2024
Q1 | $13.8M | Sell |
39,854
-22,098
| -36% | -$7.64M | ﹤0.01% | 874 |
|
|
2023
Q4 | $20M | Buy |
61,952
+16,747
| +37% | +$5.41M | 0.01% | 736 |
|
|
2023
Q3 | $16.2M | Buy |
45,205
+1,245
| +3% | +$446K | 0.01% | 732 |
|
|
2023
Q2 | $16.7M | Buy |
43,960
+20,554
| +88% | +$7.79M | 0.01% | 735 |
|
|
2023
Q1 | $11.2M | Sell |
23,406
-42,996
| -65% | -$20.6M | 0.01% | 771 |
|
|
2022
Q4 | $27.9M | Buy |
66,402
+12,293
| +23% | +$5.17M | 0.01% | 531 |
|
|
2022
Q3 | $22.6M | Buy |
54,109
+30,863
| +133% | +$12.9M | 0.02% | 545 |
|
|
2022
Q2 | $11.5M | Sell |
23,246
-4,628
| -17% | -$2.29M | 0.01% | 777 |
|
|
2022
Q1 | $15.7M | Sell |
27,874
-8,911
| -24% | -$5.02M | 0.01% | 740 |
|
|
2021
Q4 | $27.8M | Sell |
36,785
-8,878
| -19% | -$6.71M | 0.01% | 586 |
|
|
2021
Q3 | $34.1M | Buy |
45,663
+12,847
| +39% | +$9.58M | 0.02% | 524 |
|
|
2021
Q2 | $21.1M | Buy |
32,816
+509
| +2% | +$328K | 0.01% | 672 |
|
|
2021
Q1 | $18.5M | Buy |
32,307
+11,397
| +55% | +$6.51M | 0.01% | 646 |
|
|
2020
Q4 | $12.2M | Sell |
20,910
-40
| -0.2% | -$23.3K | 0.01% | 728 |
|
|
2020
Q3 | $10.8M | Buy |
20,950
+419
| +2% | +$216K | 0.01% | 698 |
|
|
2020
Q2 | $9.27M | Sell |
20,531
-6,354
| -24% | -$2.87M | 0.01% | 690 |
|
|
2020
Q1 | $9.43M | Buy |
26,885
+353
| +1% | +$124K | 0.01% | 630 |
|
|
2019
Q4 | $9.82M | Sell |
26,532
-8,193
| -24% | -$3.03M | 0.01% | 857 |
|
|
2019
Q3 | $11.6M | Buy |
34,725
+3,528
| +11% | +$1.17M | 0.01% | 723 |
|
|
2019
Q2 | $9.75M | Buy |
31,197
+26,508
| +565% | +$8.29M | 0.01% | 839 |
|
|
2019
Q1 | $1.43M | Sell |
4,689
-42,017
| -90% | -$12.8M | ﹤0.01% | 1854 |
|
|
2018
Q4 | $10.8M | Buy |
46,706
+39,653
| +562% | +$9.21M | 0.01% | 685 |
|
|
2018
Q3 | $2.21M | Buy |
7,053
+2,784
| +65% | +$872K | ﹤0.01% | 1700 |
|
|
2018
Q2 | $1.23M | Sell |
4,269
-1,216
| -22% | -$351K | ﹤0.01% | 1719 |
|
|
2018
Q1 | $1.37M | Sell |
5,485
-2,052
| -27% | -$513K | ﹤0.01% | 1589 |
|
|
2017
Q4 | $1.8M | Buy |
7,537
+6,157
| +446% | +$1.47M | ﹤0.01% | 1313 |
|
|
2017
Q3 | $307K | Sell |
1,380
-2,917
| -68% | -$649K | ﹤0.01% | 2173 |
|
|
2017
Q2 | $972K | Buy |
4,297
+56
| +1% | +$12.7K | ﹤0.01% | 1580 |
|
|
2017
Q1 | $846K | Buy |
4,241
+3,321
| +361% | +$662K | ﹤0.01% | 1654 |
|
|
2016
Q4 | $168K | Buy |
920
+370
| +67% | +$67.6K | ﹤0.01% | 2378 |
|
|
2016
Q3 | $91K | Sell |
550
-502
| -48% | -$83.1K | ﹤0.01% | 2468 |
|
|
2016
Q2 | $149K | Buy |
1,052
+384
| +57% | +$54.4K | ﹤0.01% | 2215 |
|
|
2016
Q1 | $91K | Buy |
668
+54
| +9% | +$7.36K | ﹤0.01% | 2347 |
|
|
2015
Q4 | $85K | Buy |
614
+39
| +7% | +$5.4K | ﹤0.01% | 2349 |
|
|
2015
Q3 | $77K | Sell |
575
-108
| -16% | -$14.5K | ﹤0.01% | 2456 |
|
|
2015
Q2 | $103K | Sell |
683
-3,396
| -83% | -$512K | ﹤0.01% | 2345 |
|
|
2015
Q1 | $551K | Buy |
4,079
+446
| +12% | +$60.2K | ﹤0.01% | 1887 |
|
|
2014
Q4 | $435K | Sell |
3,633
-933
| -20% | -$112K | ﹤0.01% | 2060 |
|
|
2014
Q3 | $516K | Sell |
4,566
-1,181
| -21% | -$133K | ﹤0.01% | 1950 |
|
|
2014
Q2 | $684K | Sell |
5,747
-4,906
| -46% | -$584K | ﹤0.01% | 1869 |
|
|
2014
Q1 | $1.36M | Buy |
10,653
+2,025
| +23% | +$259K | ﹤0.01% | 1509 |
|
|
2013
Q4 | $1.06M | Buy |
8,628
+3,956
| +85% | +$486K | ﹤0.01% | 1732 |
|
|
2013
Q3 | $547K | Buy |
4,672
+1,725
| +59% | +$202K | ﹤0.01% | 2065 |
|
|
2013
Q2 | $330K | Buy |
+2,947
| New | +$330K | ﹤0.01% | 2446 |
|